These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36986677)

  • 1. Radioimmune Imaging of α
    Signore A; Bonfiglio R; Varani M; Galli F; Campagna G; Desco M; Cussó L; Mattei M; Wunder A; Borri F; Lupo MT; Bonanno E
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation that blocks integrin α
    Zhang H; Zheng Y; Pan Y; Lin C; Wang S; Yan Z; Lu L; Ge G; Li J; Zeng YA; Chen J
    BMC Biol; 2020 Jun; 18(1):64. PubMed ID: 32522281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis.
    Lenzen H; Qian J; Manns MP; Seidler U; Jörns A
    J Mol Med (Berl); 2018 Aug; 96(8):831-843. PubMed ID: 29967942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
    Ungar B; Kopylov U; Yavzori M; Fudim E; Picard O; Lahat A; Coscas D; Waterman M; Haj-Natour O; Orbach-Zingboim N; Mao R; Chen M; Chowers Y; Eliakim R; Ben-Horin S
    Clin Gastroenterol Hepatol; 2018 May; 16(5):697-705.e7. PubMed ID: 29223444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis.
    Murthy S; Cooper HS; Yoshitake H; Meyer C; Meyer CJ; Murthy NS
    Aliment Pharmacol Ther; 1999 Feb; 13(2):251-60. PubMed ID: 10102957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing.
    Schleier L; Wiendl M; Heidbreder K; Binder MT; Atreya R; Rath T; Becker E; Schulz-Kuhnt A; Stahl A; Schulze LL; Ullrich K; Merz SF; Bornemann L; Gunzer M; Watson AJM; Neufert C; Atreya I; Neurath MF; Zundler S
    Gut; 2020 Feb; 69(2):252-263. PubMed ID: 31092589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
    Tilg H; Kaser A
    Curr Opin Investig Drugs; 2010 Nov; 11(11):1295-304. PubMed ID: 21157649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice.
    López-Posadas R; Fastancz P; Martínez-Sánchez LDC; Panteleev-Ivlev J; Thonn V; Kisseleva T; Becker LS; Schulz-Kuhnt A; Zundler S; Wirtz S; Atreya R; Carlé B; Friedrich O; Schürmann S; Waldner MJ; Neufert C; Brakebusch CH; Bergö MO; Neurath MF; Atreya I
    Gastroenterology; 2019 Nov; 157(5):1293-1309. PubMed ID: 31302143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of radiolabelled anti-TNFa monoclonal antibodies for diagnostic purposes and therapy evaluation.
    Glaudemans AW; Dierckx RA; Kallenberg CG; Fuentes KL
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):639-53. PubMed ID: 21221071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab.
    Domenis R; Marino M; Cifù A; Scardino G; Curcio F; Fabris M
    PLoS One; 2020; 15(11):e0242342. PubMed ID: 33180848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases.
    Rath T; Billmeier U; Ferrazzi F; Vieth M; Ekici A; Neurath MF; Atreya R
    Front Immunol; 2018; 9():1700. PubMed ID: 30131801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 99mTc-labelled monoclonal antibody 1D09C3 for molecular imaging of major histocompatibility complex class II protein expression.
    Malviya G; de Vries EF; Dierckx RA; Signore A
    Mol Imaging Biol; 2011 Oct; 13(5):930-9. PubMed ID: 20812032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD).
    Liu C; Jiang Y; Liu G; Guo Z; Jin Q; Long D; Zhou W; Qian K; Zhao H; Liu K
    Biochem Pharmacol; 2022 Aug; 202():115119. PubMed ID: 35667414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a 99mTc labeled anti-TNFalpha monoclonal antibody in Crohn's disease: in vitro and in vivo studies.
    D'Alessandria C; Malviya G; Viscido A; Aratari A; Maccioni F; Amato A; Scopinaro F; Caprilli R; Signore A
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):334-42. PubMed ID: 17464276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis.
    Halpert G; Eitan T; Voronov E; Apte RN; Rath-Wolfson L; Albeck M; Kalechman Y; Sredni B
    J Biol Chem; 2014 Jun; 289(24):17215-27. PubMed ID: 24764299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin alpha2beta1 regulates neutrophil recruitment and inflammatory activity in experimental colitis in mice.
    Lundberg S; Lindholm J; Lindbom L; Hellström PM; Werr J
    Inflamm Bowel Dis; 2006 Mar; 12(3):172-7. PubMed ID: 16534417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin α4β7 and Fails to Prevent Mucosal Transmission of SHIV-SF162P3.
    Arrode-Brusés G; Goode D; Kleinbeck K; Wilk J; Frank I; Byrareddy S; Arthos J; Grasperge B; Blanchard J; Zydowsky T; Gettie A; Martinelli E
    PLoS Pathog; 2016 Jun; 12(6):e1005720. PubMed ID: 27348748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis.
    Freise AC; Zettlitz KA; Salazar FB; Tavaré R; Tsai WK; Chatziioannou AF; Rozengurt N; Braun J; Wu AM
    J Nucl Med; 2018 Jun; 59(6):980-985. PubMed ID: 29326360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis.
    Petito V; Graziani C; Lopetuso LR; Fossati M; Battaglia A; Arena V; Scannone D; Quaranta G; Quagliariello A; Del Chierico F; Putignani L; Masucci L; Sanguinetti M; Sgambato A; Gasbarrini A; Scaldaferri F
    World J Gastroenterol; 2019 Mar; 25(12):1465-1477. PubMed ID: 30948910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.
    Boden EK; Shows DM; Chiorean MV; Lord JD
    Dig Dis Sci; 2018 Sep; 63(9):2419-2429. PubMed ID: 29372476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.